Literature DB >> 26666514

2015 ACC/AHA Focused Update of Secondary Prevention Lipid Performance Measures: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.

Joseph P Drozda, T Bruce Ferguson, Hani Jneid, Harlan M Krumholz, Brahmajee K Nallamothu, Jeffrey W Olin, Henry H Ting, Paul A Heidenreich, Nancy M Albert, Paul S Chan, Lesley H Curtis, T Bruce Ferguson, Gregg C Fonarow, P Michael Ho, Sean O'Brien, Andrea M Russo, Randal J Thomas, Henry H Ting, Paul D Varosy.   

Abstract

Entities:  

Keywords:  AHA Scientific Statements; coronary artery disease; health policy and outcome research; myocardial infarction; percutaneous coronary intervention; peripheral arterial disease; shared decision making; statins

Mesh：

Substances：

Year:  2015        PMID： 26666514     DOI： 10.1161/HCQ.0000000000000014

Source DB:  PubMed          Journal:  Circ Cardiovasc Qual Outcomes        ISSN： 1941-7713


× No keyword cloud information.
  3 in total

1.  Adherence to lipid management guidelines is associated with lower mortality and major adverse limb events in patients undergoing revascularization for chronic limb-threatening ischemia.

Authors:  Thomas F X O'Donnell; Sarah E Deery; Jeremy D Darling; Katie E Shean; Murray A Mittleman; Gabrielle N Yee; Matthew R Dernbach; Marc L Schermerhorn
Journal:  J Vasc Surg       Date:  2017-05-12       Impact factor: 4.268

2.  Trends in low-density lipoprotein-cholesterol blood values between 2012 and 2017 suggest sluggish adoption of the recent 2013 treatment guidelines.

Authors:  H Robert Superko; Paul T Williams; Michael Dansinger; Ernst Schaefer
Journal:  Clin Cardiol       Date:  2018-11-30       Impact factor: 2.882

3.  Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.

Authors: 
Journal:  Lancet       Date:  2016-10-08       Impact factor: 79.321
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.